Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2024 of 5804
-
New online tool aims to ease breast cancer symptoms for young women
Symptom relief OngoingThis research study is being done to monitor common symptoms and behavior, and to provide supportive care information and peer support, as well as research opportunities for young women ages of 18-39 years old who have been diagnosed with stage 0-IV stage breast cancer using a we…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New combo aims to tackle tough prostate cancer
Disease control OngoingThis is a phase 1, open label, prospective, non-randomized single arm study combining Radium-223 with nivolumab in men with metastatic castration resistant prostate cancer.
Phase: PHASE1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
App-Based monitoring shows promise for IBD patients
Disease control CompletedM-TECCU is a study: multicenter, randomized and open. It consists of two parallel groups to compare the efficacy of the TECCU web-based telemonitoring system to achieve and maintain activity remission in patients with moderate-high complexity inflammatory bowel disease compared t…
Phase: NA • Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can smartphones and wearables unlock the secrets of atrial fibrillation?
Knowledge-focused ENROLLING_BY_INVITATIONAtrial fibrillation (also known as AFib or AF) is the most common abnormal heart rhythm and results in an irregular beating of the heart. Currently, there is no way of identifying patients at most risk for the development or progression of AFib or those that will best respond to …
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Could a simple quiz match you to the perfect back pain exercise?
Knowledge-focused CompletedExercise therapy is the most recommended treatment for chronic low back pain. There is a wide range of exercises available and research studies have shown that no exercise is superior to another. The problem is that the effects of exercise in reducing pain and disability are smal…
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Stand up again: exercise program aims to get ICU survivors out of bed
Symptom relief Completed"Sit-to-stand" is key to independent living. For intensive care unit (ICU) survivors, failure to perform sit-to-stand results in bed-bound status, unable participating in important activities of daily living (ADLs) or instrumental ADLs. Recent studies indicated that 31% of ICU su…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New radiation approach aims to tame pituitary tumors with fewer side effects
Disease control CompletedSingle session stereotactic radiosurgery (SRS) is commonly used for patients with non-functioning adenomas. However the SRS can be limited by the proximity of the tumor with the surrounding critical structures (i.e., the optic chiasm). The goal of the present prospective phase I…
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare anemia: drug combo shows promise
Disease control CompletedThis is an open-label, single-arm study to evaluate the safety and efficacy of bortezomib plus dexamethasone for acquired pure red cell aplasia failure or relapse after first-line treatment.
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New eye drop shows promise for rare corneal disease
Disease control CompletedThis study is to evaluate the safety and efficacy of OXERVATE® 0.002% (20 mcg/mL) cenegermin-bkbj ophthalmic solution in patients with Stage 1 neurotrophic keratitis (NK).
Phase: PHASE4 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
33,000 hepatitis b patients enrolled in landmark Long-Term treatment study
Knowledge-focused Recruiting nowThe goal of this observational, multicenter , real-world study is to evaluate the long-term outcomes of different antiviral therapies in adults with chronic hepatitis B (CHB). The main questions it aims to answer are: What is the 5-year incidence of hepatocellular carcinoma (HCC)…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New PET tracer could sharpen sarcoma detection
Diagnosis OngoingThis early phase I trial studies an imaging technique called 68Ga-FAPi-46 PET/CT to determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulates in normal and cancer tissues in patients with sarcoma. PET is an established imaging technique that utilizes small am…
Phase: EARLY_PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
New synthetic hormone shows promise for rare calcium disorder
Disease control CompletedThis study is investigating the safety, tolerability, pharmacodynamics and pharmacokinetics of AZP-3601 following single and repeated administration in both healthy volunteers and patients with chronic hypoparathyroidism (cHP) The protocol includes 3 parts: * Part A: first-in-h…
Phase: PHASE1, PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:03 UTC
-
Blood test may improve cancer care for colorectal and lung cancer patients
Knowledge-focused OngoingCOPE is a biology driven protocol with 2 independent, multicentric, two-arm non-comparative randomized (2:1) phase II trials in 2 distinct populations: colorectal cancer patients and non-small-lung cancer patients. For each phase II trial, patient will be randomized between two …
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
New CGM system aims to personalize diabetes management
Disease control CompletedThis study is evaluate the superior efficacy of a Continuous Glucose Monitor (CGM)-based advisory system in Type 1 Diabetes Mellitus (T1DM), as compared to Sensor Augmented Mode (SAM) therapy, and with characterizing the impact of psycho-behavioral factors on system performance, …
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a supplement and exercise improve stamina in Friedreich's ataxia?
Symptom relief CompletedRandomized, placebo-controlled trial with a 2x2 factorial design testing the effects of an NAD+ precursor (NR) and exercise on Peak VO2 and Si in Friedreich's Ataxia (FA). The primary objective of this research is to measure the effect of combination administration (NR + exercis…
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a liver artery shot make cancer treatment more effective?
Disease control OngoingThis study will look at whether it is practical and safe to give Lutathera directly into an artery of the liver (hepatic intraarterial infusion). The researchers will compare the effects of hepatic intraarterial infusion in the liver with the effects of the standard approach (int…
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Zapping the brain to help stroke survivors walk better
Disease control Recruiting nowAchieving functional ambulation post stroke continues to be a challenge for stroke survivors, clinicians, and researchers. In the effort to enhance outcomes of motor training, cortical priming using brain stimulation has emerged as a promising adjuvant to conventional rehabilitat…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Shoulder surgery showdown: which replacement works best?
Disease control Recruiting nowThere are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized st…
Phase: NA • Sponsor: La Tour Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Nicotine pouches linked to worse health and more school misses in teens?
Knowledge-focused CompletedThis cross-sectional study investigates whether the use of nicotine pouches is associated with poorer mental and physical well-being and increased school absence among Danish adolescents. The study population comprises 13-18-year-old students from public schools in Aarhus Munici…
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Which surgery works best for kids with hirschsprung disease? new study compares two techniques
Disease control CompletedCompare the functional and surgical outcomes of laparoscopic-assisted Swenson-like (LASwL) and laparoscopic-assisted Soave (LASo) pull through in children with HD.
Phase: PHASE4 • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC